Portal de investigação
COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Airborne food and aeroallergens levels in healthcare settings. An unaccounted but potentially relevant source of exposure?
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (Aeroallergens) . 2020
Eosinophil cationic protein (ECP) correlates with eosinophil cell counts in the induced sputum of elite swimmers
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico (ECP) . 2021
How exercise, physical activity and diet modulate immune and stress responses
Investigador Principal: André Miguel Afonso de Sousa Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Rama TA,Miranda J,Silva D,Amaral L,Castro E,Coimbra A,Moreira A,Placido JL. COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication. Vaccines. 2022. 10. (5):p. 718-718. IF:7,800. (1).
